Divi’s Laboratories Q2 Results 2025 Highlights: Net Profit Surged by 38.10% & Revenue Up 16.12% YoY

Name: Stock Advisory service In India
Brand: univest
Rating: 4.4 (197000 reviews)

Posted by : sachet | Tue Nov 11 2025

Divi’s Laboratories Q2 Results 2025 Highlights: Net Profit Surged by 38.10% & Revenue Up 16.12% YoY

Click and Sign Up to Get Live Updates on Q2 Results

Divi’s Laboratories Q2 Results FY26: During Q2 FY26, Divi’s Laboratories’ profit increased 35.10% YoY, while revenue increased by 16.12% YoY. The company posted robust numbers, with Q2 PAT at ₹689.00 crores and revenue at ₹2,715.00 crores. Divi’s Laboratories showed its Q2 results on 7th November 2025.

Table of Contents

Divi’s Laboratories Q2 Results FY26: Extracts of FY25 & FY26

Particulars	Consolidated Figures		Standalone Figures
	30th Sep 2025	30 Sept 2024	30th Sept 2025	30th Sept 2024
Revenue from Operations	₹2,715.00	₹2,338.00	₹2,660.00	₹2,302.00
Profit Before Tax (PBT)	₹1,033.00	₹822.00	₹1,041.00	₹834.00
Profit After Tax (PAT)	₹689.00	₹510.00	₹696.00	₹518.00

Divi’s Laboratories Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

Divi’s Laboratories clocked Q2 FY26 consolidated revenue of ₹2,715.00 crores vs ₹2,338.00 crores.
On the profit front, Divi’s Laboratories earned a consolidated PAT of ₹689.00 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹510.00 crore.
According to the consolidated figures, Divi’s Laboratories’ quarterly PAT increased by 35.10% YoY, while revenue increased by 16.12%.
Divi’s Laboratories clocked Q2 FY26 standalone revenue of ₹2,660.00 crores vs ₹2,302.00 crores.
On the profit front, Divi’s Laboratories earned a standalone PAT of ₹696.00 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹518.00 crore.
According to the standalone figures, Divi’s Laboratories’ quarterly PAT increased by 34.36% YoY, while revenue increased by 15.55%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Divi’s Laboratories Share Price Performance

On the opening bell on 11th November 2025, Divi’s Laboratories shares opened at ₹6,670.00 per share. However, the initial gains have since eroded, and Divi’s Laboratories shares are currently trading at ₹6,493.50 per share, which is lower than the opening price.

Considering the long-term achievements, Divi’s Laboratories shares have yielded returns of approximately 9.25% over the past 6 months, and 1-year returns stand at 10.03%. Over the maximum timeframe, Divi’s Laboratories shares delivered a 72,022.22% return to investors.

What Analysts Expect Post Q2 Results?

Following Divi’s Laboratories’ robust Q2 results for FY26, analysts expect its share price to rise. According to analysts, Divi’s Laboratories’ share price could reach ₹6,700.00 per share in the coming year and, in a downturn, could hit ₹6,400.00 per share. However, one must ignore stock market volatility and invest in Divi’s Laboratories shares after thorough research.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.